These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16094397)

  • 1. Nitrosative and oxidative stress links dysfunctional ubiquitination to Parkinson's disease.
    Gu Z; Nakamura T; Yao D; Shi ZQ; Lipton SA
    Cell Death Differ; 2005 Sep; 12(9):1202-4. PubMed ID: 16094397
    [No Abstract]   [Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
    Ross CA; Pickart CM
    Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration.
    Uehara T; Nakamura T; Yao D; Shi ZQ; Gu Z; Ma Y; Masliah E; Nomura Y; Lipton SA
    Nature; 2006 May; 441(7092):513-7. PubMed ID: 16724068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein aggregation in the pathogenesis of familial and sporadic Parkinson's disease.
    McNaught KS; Olanow CW
    Neurobiol Aging; 2006 Apr; 27(4):530-45. PubMed ID: 16207501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-proteasome system and Parkinson's disease.
    Olanow CW; McNaught KS
    Mov Disord; 2006 Nov; 21(11):1806-23. PubMed ID: 16972273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The proteasome in Alzheimer's disease and Parkinson's disease: lessons from ubiquitin B+1.
    Hol EM; van Leeuwen FW; Fischer DF
    Trends Mol Med; 2005 Nov; 11(11):488-95. PubMed ID: 16213790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling proteasome dynamics in Parkinson's disease.
    Sneppen K; Lizana L; Jensen MH; Pigolotti S; Otzen D
    Phys Biol; 2009 May; 6(3):036005. PubMed ID: 19411740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide, S-nitrosylation and neurodegeneration.
    Chung KK; Dawson TM; Dawson VL
    Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):247-54. PubMed ID: 16191392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-proteasome system dysfunction in Parkinson's disease: current evidence and controversies.
    Lim KL
    Expert Rev Proteomics; 2007 Dec; 4(6):769-81. PubMed ID: 18067415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nuclear proteasome and the degradation of oxidatively damaged proteins.
    Voss P; Grune T
    Amino Acids; 2007; 32(4):527-34. PubMed ID: 17103119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-nitrosylation in Parkinson's disease and related neurodegenerative disorders.
    Chung KK; Dawson VL; Dawson TM
    Methods Enzymol; 2005; 396():139-50. PubMed ID: 16291229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role for oxidative stress in neurodegenerative diseases].
    Shibata N; Kobayashi M
    Brain Nerve; 2008 Feb; 60(2):157-70. PubMed ID: 18306664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 17. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome dysfunction in aged human alpha-synuclein transgenic mice.
    Chen L; Thiruchelvam MJ; Madura K; Richfield EK
    Neurobiol Dis; 2006 Jul; 23(1):120-6. PubMed ID: 16713278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rescuing defective vesicular trafficking protects against alpha-synuclein toxicity in cellular and animal models of Parkinson's disease.
    Lashuel HA; Hirling H
    ACS Chem Biol; 2006 Aug; 1(7):420-4. PubMed ID: 17168518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases.
    Mandemakers W; Morais VA; De Strooper B
    J Cell Sci; 2007 May; 120(Pt 10):1707-16. PubMed ID: 17502481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.